Skip to main content
Caplight Logo









Cardiospire

Cardiospire

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://cardiospire.com

Last Round

Grant

Oct 1, 2019

Total Funding Raised

$2.43M

Company Overview

Cardiospire is a healthcare and technology company that has developed a non-invasive hemodynamic monitoring device to assess and manage cardiovascular function in ventilated patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

remote patient monitoringRPMhemodynamic monitoringnon-invasive monitoringcardiopulmonary monitoringbreath analysismedical AIMedTechcongestive heart failureCHFCOPDchronic disease managementHealth IoTdigital healthhandheld medical devicepredictive analyticsclinician dashboard

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiospire Comparables

Compare Cardiospire with similar companies based on industry and business-model similarity.

Cardiospire comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bodyport
84%
Acorai
82%
Nanowear
80%

Cardiospire Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2019
Convertible DebtAug 14, 2019
Series AMar 1, 2016

Cardiospire Investors

Notable investors and investment history

Cardiospire investors
InvestorRounds
StartXSeries A
IT-Farm CorporationSeries A
MedTech InnovatorGrant
Signatures CapitalSeries A
TheraNovaSeries A
Synergy VenturesSeries A
Johnson & Johnson Innovation - JLABSGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2019

    $125K grant received from Johnson & Johnson Innovation - JLABS.

  • Aug 14, 2019

    $1.3M raised in convertible debt.

Cardiospire Filings

Explore SEC and related filing metadata, where available.

Cardiospire filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cardiospire's valuation, stock price, and market status.

Is Cardiospire a public or private company?

Cardiospire is a private company.

What is the current stock price of Cardiospire?

Cardiospire is a private company with no public stock price. No recent secondary market data is available.

How much is Cardiospire worth (valuation)?

Valuation information for Cardiospire is not publicly available.

Can I buy Cardiospire stock?

Cardiospire shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cardiospire's last funding round?

Cardiospire's most recent funding round was Grant on October 1, 2019.

Who are the main investors in Cardiospire?

Key investors in Cardiospire include StartX, IT-Farm Corporation, MedTech Innovator, Signatures Capital, Theranova.

Will Cardiospire IPO soon?

No public IPO plans have been announced for Cardiospire.

How can I track Cardiospire secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cardiospire's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2015
Last FundingOct 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?